Maynard Um
-
-
-
-
-
-
-
Increasing unusual option volume: MIST APPN NXDR IRBT XPO FLWS ENTG FBIO FND
-
-
-
-
-
-
-
Milestone Pharmaceuticals prices $52.5 million public offering
-
-
-
-
-
-
-
Milestone Pharmaceuticals (MIST): FDA Issues Complete Response Letter for Etripamil for PSVT
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
-
-
-
-
-
-
-
Milestone Pharmaceuticals Inc. (MIST) Tops Q2 EPS by 5c
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

